logo

US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy

By: theblockbeats.news|2025/08/04 13:02:14

BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.


This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.

The Ether Machine has announced an increase in holdings of 10,605 ETH, bringing the total holdings to 345,362 ETH.
US Stock DFDV Announces Increase in Holding of 110,000 SOL, Bringing Total Holdings to 1,293,000 SOL

You may also like

Share
copy

Gainers

Latest Crypto News

01:15

「Whale」 Ethereum Multi-Step again Partially Liquidated, Account Balance Fell Below $270,000

01:15

Cryptocurrency Fear and Greed Index Drops to 24, Market Enters "Extreme Fear" Mode Again

01:15

「Cool-headed King of Shorting」 entered a new MON short position, earlier this morning closed a long position on BTC and SOL before reversing to open a short position

01:15

In the past 4 hours, the entire network has seen $435 million in liquidations, with longs accounting for $424 million of the total.

01:15

「CZ's Countertrade」 Long Position's Unrealized Loss Expands to $26 Million, Now the Largest Long on Hyperliquid for ETH and XRP

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]